QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 16,220
+530 (3.38%)
At close: Mar 12, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 186.24 billion as of March 13, 2026.
Market Cap
186.24B
Enterprise Value
189.34B
Revenue
13.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,220.00
Market Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 186.24B, a decrease of -6.86%. That is a compound annual growth rate of -25.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 186.24B | 5.33% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABION | 243.27B |
| Genome & Company | 243.20B |
| Kangstem Biotech | 212.56B |
| TiumBio | 207.04B |
| Prestige Biologics | 202.16B |
| ISU Abxis | 201.57B |
| Ensol Biosciences | 196.42B |
| IMGT Co.,Ltd. | 122.47B |